Evaluation of Healthcare Resource Utilization and Costs Among Patients with Chronic Myeloid Leukemia after Disease Progression

被引：0
|
作者：
Jabbour, Elias [1 ]
Lin, Jay [2 ]
Siegartel, Lisa R. [3 ]
Lingohr-Smith, Melissa [2 ]
Menges, Brandy [2 ]
Makenbaeva, Dinara [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Novosys Hlth, Green Brook, NJ USA
[3] Bristol Myers Squibb, Plainsboro, NJ 08536 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3573.3573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3573
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase
    Jabbour, Elias J.
    Lin, Jay
    Siegartel, Lisa R.
    Lingohr-Smith, Melissa
    Menges, Brandy
    Makenbaeva, Dinara
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (09) : 1007 - 1012
  • [2] Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia
    Hagiwara, May
    Sharma, Arati
    Chung, Karen C.
    Delea, Thomas E.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (11) : 1119 - 1130
  • [3] Evaluation of healthcare, resource utilization (HRU) and costs of anemia among chronic obstructive pulmonary disease (COPD) patients
    Halpern, MT
    Schmier, JK
    Zilberberg, M
    Lau, E
    CHEST, 2005, 128 (04) : 257S - 257S
  • [4] Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients
    Wu, Eric Q.
    Johnson, Scott
    Beaulieu, Nicolas
    Arana, Mateo
    Bollu, Vamsi
    Guo, Amy
    Coombs, John
    Feng, Weiwei
    Cortes, Jorge
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (01) : 61 - 69
  • [5] Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States
    Jabbour, Elias J.
    Siegartel, Lisa R.
    Lin, Jay
    Lingohr-Smith, Melissa
    Menges, Brandy
    Makenbaeva, Dinara
    LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 668 - 674
  • [6] HEALTHCARE RESOURCE UTILIZATION AND COSTS AMONG PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UNITED STATES
    Cameron, A.
    Barrett, M.
    Malik, A.
    Woodford, C.
    Alpert, N.
    Vuong, V.
    Boers, E.
    Kaye, L.
    Sterling, K. L.
    VALUE IN HEALTH, 2022, 25 (12) : S176 - S176
  • [7] Real-World Treatment Patterns, Healthcare Resource Utilization and Associated Costs Among Patients with Chronic Myeloid Leukemia in Later Lines of Therapy
    Atallah, Ehab L.
    Maegawa, Rodrigo
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Guerin, Annie
    Patwardhan, Pallavi
    BLOOD, 2020, 136
  • [8] Healthcare Resource Utilization and Associated Costs Among Patients with Chronic Myeloid Leukemia by Line of Therapy in the United States (US) from a Commercial Perspective
    Atallah, Ehab
    Maegawa, Rodrigo
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Guerin, Annie
    Patwardhan, Pallavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S333 - S333
  • [9] Annual Healthcare Resource Utilization and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia
    Tabah, Ashley
    Knoth, Russell L.
    Huggar, David
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    Leblanc, Thomas W.
    BLOOD, 2020, 136
  • [10] ANNUAL HEALTHCARE RESOURCE UTILIZATION AND COSTS IN US PATIENTS DIAGNOSED WITH RELAPSED ACUTE MYELOID LEUKEMIA
    Huggar, D.
    Knoth, R. L.
    Cao, Z.
    Lipkin, C.
    Copher, R.
    LeBlanc, T. W.
    VALUE IN HEALTH, 2021, 24 : S28 - S28
12345